Australia and New Zealand both have national medicines policies that aim for equitable…

Question 2) Australia and New Zealand both have national medicines policies that aim for equitable access to cost-effective and safe medicines. However, each country has adopted a different approach. Australia has an uncapped system of funding medicines, with the Pharmaceutical Benefits Advisory Committee (PBAC) reviewing submission for new medicines to be listed on the Pharmaceutical Benefits Committee based on selected criteria. New Zealand has an equivalent agency, PHARMAC, which decides which pharmaceuticals to publicly fund. However, PHARMAC operates under a fixed budget constraint, and adopts different procurement mechanisms for medicines such as competitive tendering. Compare and critically review Australia and New Zealand’s policies for providing access to prescription medicines based on need not ability to pay. Make a recommendation as to whether Australia should or should not adopt the New Zealand model.

Don't use plagiarized sources. Get Your Custom Essay on
Australia and New Zealand both have national medicines policies that aim for equitable…
For as low as $13/Page
Order Essay

Document Preview:

PHAR6006 Pharmacoeconomics
Assignment
_____________________________________________________________________________
Select and answer ONE of the three questions shown below. The maximum word count is 1,500
words, and any word count over 2,000 words will not be marked. The question will be marked
out of 25 using the marking key shown on the next page.
Please use the peer-reviewed literature as much as possible to support the arguments you
present.
The assignment is worth 50% of the final mark in this Unit.
Question 1
In a research report titled Shifting the Dial published in 2017, the Productivity Commission
recommended a new model of pharmacy be adopted with a ‘move away from community
pharmacy as the vehicle for dispensing medicines to a model that anticipates automatic
dispending in a majority of locations, supervised by a suitable qualified person’
(Recommendation 2.5). The suitably qualified person would have ‘good social skills and
trustworthiness (with support from information technologies), but would not need the clinical
and scientific abilities of pharmacists’ (Recommendation 2.4). In the new model, pharmacists
would have a new role in the multi-disciplinary management of complex and chronic condition.
This role would be defined in consultation with Primary Health Networks, Local Hospital
Networks, the various medical colleges and any other relevant clinical bodies.
Critically discuss these recommendations by the Productivity Commission taking into account
viewpoints of different stakeholders and the possible impact on population health and the
economy.
Question 2
Australia and New Zealand both have national medicines policies that aim for equitable access
to cost-effective and safe medicines. However, each country has adopted a different approach.
Australia has an uncapped system of funding medicines, with the Pharmaceutical Benefits
Advisory Committee (PBAC) reviewing submission for new medicines to be listed on the…

Attachments: